Astroglial cells derived from lateral and medial midbrain sectors differ in their abilities to support neuritic growth of midbrain neurons in cocultures. These different properties of the two types of cells may be related to the composition of their extracellular matrix. We have studied the synthesis and secretion of sulfated glycosaminoglycans (GAGs) by the two cell types under control conditions and ß-Dxyloside-stimulated conditions, that stimulate the ability to synthesize and release GAGs. We have confirmed that both cell types synthesize and secrete heparan sulfate and chondroitin sulfate. Only slight differences were observed between the proportions of the two GAGs produced by the two types of cells after a 24-h labeling period. However, a marked difference was observed between the GAGs produced by the astroglial cells derived from lateral and medial midbrain sectors. The medial cells, which contain derivatives of the tectal and tegmental midline radial glia, synthesized and secreted ~2.3 times more chondroitin sulfate than lateral cells. The synthesis of heparan sulfate was only slightly modified by the addition of ß-Dxyloside. Overall, these results indicate that astroglial cells derived from the two midbrain sectors have marked differences in their capacity to synthesize chondroitin sulfate. Under in vivo conditions or a long period of in vitro culture, they may produce extracellular matrix at concentrations which may differentially affect neuritic growth.
Introduction
The central nervous system midline plays an important role in growth cone guidance by virtue of its varied cellular and molecular composition (1) (2) (3) . Midline resident cells and/ or extracellular matrix (ECM) may be involved in the control of navigation of specific axon populations. One of such populations is that of the midbrain medial radial glia which differ from their lateral counterparts in their schedule of cell proliferation (4), cytoskeletal proteins, glycogen content, and interaction with afferent axons (1, (5) (6) (7) . Since some distinctive features are also found in the mouse (8, 9) , we have developed an in vitro model of astrocyte cultures of the lateral and medial sectors of the embryonic mouse midbrain (Figure 1 ) that differ in their ability to support neuritic growth of midbrain neurons (10) . Such cultures also differ in the pattern assumed by the ECM glycoprotein laminin (11) so that neurons growing onto lateral astrocytic carpets, in which laminin displays a fibrillar configuration, extend long neurites, while neurons plated onto medial astrocytic carpets, where laminin assumes a punctate pattern, show no or only stunted processes. In addition, preliminary results suggest that astroglial cells derived from lateral and medial midbrain sectors differ in their glycosaminoglycan (GAG) composition (12) . Proteoglycans form another class of macromolecules produced by astrocytes that can exert either growth-promoting or growth-inhibiting activities depending on their exact molecular composition and mode of presentation to the neurons (13) (14) (15) . Many studies also suggest that the GAG parts of these molecules are responsible for effects on neuronal morphology (16) (17) (18) (19) .
We now report further characterization of the sulfated GAGs synthesized by the two types of astroglial cells. The major difference occurs in the GAGs secreted into the culture medium. In the presence of ß-Dxyloside, astroglial cells derived from the medial midbrain sectors secrete higher amounts of chondroitin sulfate than the cells derived from lateral midbrain. Our results show that differences in the composition and amounts of a given GAG molecule may be involved in control of axon growth through the midline.
Material and Methods

Cell cultures
Primary glial cultures from midbrains of 14-day-old Swiss mouse embryos (E14) were prepared as previously described (10) . Briefly, midbrains were removed, carefully stripped off the meninges and maintained in PBS glucose. At this embryonic stage, the midbrains have the shape of a slightly curved cylinder and can first be cut as in an openbook manner. Subsequently, regions adjacent to the tectal and tegmental midline, comprising about one third of the midbrain circumference, were separated and denoted the medial region while the remaining two thirds were considered the lateral region (Figure 1 ). Lateral and medial regions were dissociated into single cells in a medium consisting of DMEM with F12 (Gibco, Gaithersburg, MD, USA) enriched with glucose, glutamine and sodium bicarbonate as indicated above. Dissociated cells were plated with the same medium as for dissociation, supplemented with 10% FCS. Cultures were kept for 3 weeks, with changes of the DMEM-F12-10% FCS medium every 3-4 days.
Repeated analyses of the confluent cultures with antibodies binding to astrocytes (anti-GFAP), neurons (anti-beta 3 tubulin) or oligodendrocytes (anti-CNPase) as well as tests with an isolectin (BS1B4 of Griffonia simplicifolia) that recognizes microglial cells have shown that virtually all cells in either type of culture are astrocytes (see 
Labeling of sulfated GAGs from lateral and medial glial cell cultures
Lateral and medial glial cell cultures that reached confluence were treated with 30 µCi of H 2 35 SO 4 in DMEM-F12-10% FCS medium. Cultures were incubated in this medium at 37 o C in a humidified atmosphere containing 5% CO 2 for 24 h.
Isolation of sulfated GAGs from lateral or medial glial cell cultures
Sulfated GAGs were isolated from the pericellular, intracellular and extracellular compartments of astrocyte cultures from lateral and medial sectors of embryonic mouse midbrain as previously described for other types of cells (21, 22) , as follows.
Essentially, at the completion of the labeling period, conditioned media containing either the lateral or medial soluble extracellular GAGs were removed and centrifuged (1000 rpm for 5 min) to remove any cell debris and stored at -20 o C until required. The cells were rinsed with PBS, pH 7.4, being detached by incubation with 2 ml of 0.25% (w/v) trypsin and 0.05% EDTA in PBS for 10 min at 37 o C. Centrifugation of the trypsin-treated cells (2,000 g for 10 min at room temperature) separated the supernatant and cell pellet, which contained the pericellular and intracellular GAGs, respectively. These fractions from lateral and medial glial cultures were incubated again for 12 h at 37 o C with 2 ml PBS, pH 7.4, containing 0.05% trypsin and 0.05% EDTA, and then dialyzed against distilled water. The samples were further incubated with 10 mg papain (Sigma Chemical Co., St. Louis, MO, USA) in the presence of 5 mM EDTA and 5 mM cysteine at 60 o C for 24 h. The 35 Slabeled GAGs were purified on a DEAEcellulose column, as described below.
For isolation of extracellular GAGs, the previously collected lateral or medial incubation medium was incubated with 10 mg papain in the presence of 5 mM EDTA and 5 mM cysteine at 60 o C for 24 h, dialyzed against distilled water, and applied to a DEAE-cellulose column (3.5 x 2.5 cm) equilibrated with 50 mM sodium acetate buffer, pH 5.0. The column was washed with 100 ml of the same buffer and then eluted stepwise with 25 ml of 0.1 M NaCl in the same acetate buffer. The 35 S-GAGs were eluted from the column with 1.0 M NaCl and exhaustively dialyzed against distilled water. The dialyzed GAG samples from lateral or medial media were lyophilized and dissolved in 0.2 ml distilled water.
Agarose gel electrophoresis
Agarose gel electrophoresis was carried out as previously described (22) . Approximately 1,000 cpm of 35 S-GAGs from cellassociated fractions or secreted into the culture medium of lateral and medial glial cell cultures before and after chondroitin lyase digestion or deaminative cleavage with nitrous acid, as well as a mixture of standard chondroitin 4-sulfate, dermatan sulfate and heparan sulfate (10 µg of each) were applied to 0.5% agarose gels in 0.05 M 1,3-diaminopropane:acetate, pH 9.0. After electrophoresis, GAGs were fixed in the gel with 0.1% N-cetyl-N,N,N-trimethylammonium bromide in water, and stained with 0.1% toluidine blue in acetic acid:ethanol:water (0.1:5:5, v/v/v). The 35 S-labeled GAGs were visualized by autoradiography of the stained gels. The radioactive bands having identical electrophoretic migration with standard GAGs were carefully scraped into 10 ml of a 0.5% PPO/toluene solution and counted in a liquid scintillation counter.
Enzymatic and nitrous acid depolymerization of the GAGs
Digestion with chondroitin lyases. Digestion with chondroitin AC or ABC lyases was carried out by the method of Saito et al. (23) . Approximately 10,000 cpm of 35 S-labeled GAGs were incubated with 0.3 units of chondroitin AC lyase or chondroitin ABC lyase for 8 h at 37 o C in 100 µl of 50 mM TrisHCl, pH 8.0, containing 5 mM EDTA and 15 mM sodium acetate.
Deamination with nitrous acid. Deamination with nitrous acid at pH 1.5 was performed as described by Shively and Conrad (24) . Briefly, approximately 10,000 cpm of 35 S-labeled GAGs were incubated with 200 µl of freshly generated HNO 2 at room temperature for 10 min. The reaction mixtures were then neutralized with 1.0 M Na 2 CO 3 .
Analysis of the 35 S-disaccharides formed by enzymatic depolymerization of extracellular 35 S-chondroitin sulfate from lateral and medial glial cultures
Purified extracellular radiolabeled sulfated GAGs were submitted to exhaustive digestion with chondroitin AC or ABC lyases (see above). After incubation, each mixture was applied to Whatman No. 1 chromatography paper and developed in isobutyric acid: 1 M NH 4 OH (5:3, v/v) for 24 h. The 35 Slabeled degradation products were detected by autoradiography of the chromatograms. The radioactive bands with chromatographic migration identical to that of standard disaccharides (a-DGlcUA-1®3-GalNAc(4SO 4 ) and a-DGlcUA-1®3-GalNAc(6SO 4 )) were cut out and counted in 10 ml of PPO/toluene.
Effects of methyl ß-D-xyloside on GAG synthesis
Lateral and medial glial cells were labeled for 24 h with H 2 35 SO 4 as described above, with or without 0.5 mM methyl ß-Dxyloside. At the end of the labeling period the secreted and cell-associated GAGs were analyzed by agarose gel electrophoresis as described above (see also Ref. 21 ).
Results and Discussion
We analyzed the amounts of 35 S-labeled GAGs found in cell-associated fractions and those secreted into the culture medium by astrocyte cells derived from lateral and medial midbrain sectors after a 24-h labeling period with [ 35 S]Na 2 SO 4 . Table 1a shows that both glial cultures expressed heparan sulfate and chondroitin sulfate in the two cellular compartments, but heparan sulfate was more abundant in the cell-associated fractions, while chondroitin sulfate predominated in the culture medium. However, it is possible to argue that the astroglial cells under in vitro culture conditions are not stimulated to synthesize GAG chains at the same intensity as observed in vivo. Another alternative is that the results reported in Table  1 for cells obtained from lateral and medial midbrain sectors may not reflect the capacity of the two cell types to synthesize GAGs, but rather the availability of the protein core required to initiate glycan assembly. In order to investigate these possibilities we stimulated GAG synthesis by the addition of ß-Dxyloside to the culture medium. This agent greatly stimulates chondroitin sulfate chain synthesis and secretion (21, 25, 26) . This procedure allowed us to evaluate more precisely the capacity of the two cell types to secrete chondroitin sulfate chains. The addition of ß-D-xyloside to cell cultures has been used as an enhancement technique to approach a different problem. Brachymorphic mice present a metabolic defect, which results in a deficient sulfation of the chondroitin sulfate chains. The defect is easily detected in cartilage due to its rapidly growing rate but not in skin fibroblast cultures. However, the addition of ß-Dxyloside to the cell cultures and the consequent increase in the synthesis of chondroitin sulfate clearly demonstrated a deficiency in the sulfation of this GAG (26) .
The addition of ß-D-xyloside led to a greater secretion of GAGs by astrocytes from medial midbrain sectors compared to lateral midbrain sectors (Table 2) .
We also investigated the effect of ß-Dxyloside on the different types of GAG chains (Table 1b) . The increased synthesis of GAGs in the presence of ß-D-xyloside was always more intense for chondroitin sulfate than for heparan sulfate chains within each compartment of the two types of cell cultures (Table  1b) . However, more significantly, the increased synthesis of chondroitin sulfate induced by ß-D-xyloside was much more intense for cells derived from the medial than from the lateral midbrain sectors. The amounts of 35 S-sulfate incorporated into chondroitin sulfate chains secreted into the culture medium by lateral and medial midbrain glial cells increased 3.16-and 10.33-fold, respectively. The synthesis of heparan sulfate was not dramatically modified by the addition of ß-D-xyloside, and in the case of the cell-surface compartment of the astrocytes from medial midbrain it was not increased at all, but slightly decreased (Table 1b) .
The addition of ß-D-xyloside to the astrocyte cultures emphasizes the difference between the synthesis of GAGs by cells derived from the lateral and medial midbrain sectors. Cells from the medial midbrain have a markedly increased capacity to synthesize and secrete chondroitin sulfate when compared with cells obtained from the lateral midbrain.
We already reported preliminary results indicating that astroglial cells derived from lateral and medial midbrain sectors differ in their GAG composition (12) . However, this initial study suggested exclusively differences in the proportion of heparan sulfate and chondroitin sulfate in the cell-associated and extracellular compartments. In the present work we expanded this study. We now report an additional difference between midbrain and lateral astrocytes, not only in GAG composition, but in the ability of midbrain astrocytes to synthesize and secrete larger amounts of one of the GAGs, chondroitin sulfate, compared to lateral glia.
Since astroglial cells derived from the lateral and medial midbrain sectors differ in their capacity to synthesize and secrete chondroitin sulfate into the culture medium, we decided to determine whether these two cell types also differ in the structure of their GAG chains. 35 S-GAGs from culture medi- Table 2 -Effect of ß-D-xyloside on the cell-associated and secreted 35 S-labeled glycosaminoglycans (GAGs) from lateral and medial glial cells.
Cultures of glial cells were incubated for 24 h with 30 µCi H 2 35 SO 4 in the presence or absence of 0.5 mM ß-D-xyloside. GAGs from cells and medium were analyzed by agarose gel electrophoresis as described in Table 1 . Values in parentheses are the ratio of total GAGs within each compartment after/before ß-D-xyloside treatment. um of lateral and medial cells were submitted to exhaustive digestion with chondroitin AC and ABC lyases. The disaccharides formed were analyzed by paper chromatography (Table 3) . GlcUA-GalNAc(4SO 4 ) accounts for about 80% of total disaccharide units found in the chondroitin sulfate synthesized by the two astroglial cells. No marked differences were observed in the disaccharide composition of the GAGs obtained from lateral and medial cells, except for a slight decrease in GlcUA-GalNAc (4SO 4 ) and a concomitant increase in IdUAGalNAc(4SO 4 ) in the chondroitin sulfate derived from medial cells. Thus, a minor amount of iduronic acid-containing disaccharide units (typical of dermatan sulfate) was also detected on the structure of extracellular chondroitin sulfate. Additional studies are necessary in order to clarify whether this iduronic acid unit is a constituent of the astroglial chondroitin sulfate, or if it constitutes a different polymer. Minor amounts of dermatan sulfate have been reported in astrocyte cultures from rat postnatal cerebral hemispheres (27) . Astrocytes, the major glial population in the nervous system, are characterized by their expression of glial fibrillary acidic protein. Recent studies have demonstrated that glial cells are also among the most functionally diverse groups of cells in the nervous system both during early development and in adults. These cells are known to synthesize and release multiple molecules, including peptide growth factors (NGF, FGF) and ECM proteins such as laminin and fibronectin. Proteoglycans are also among these astrocyte-derived neuroactive molecules, which have been suggested to play important roles in the regulation of cellular differentiation, neurite outgrowth and synaptogenesis (reviewed by Dow and Wang (15)). However, the functional significance of proteoglycans produced by astrocytes has yet to be fully elucidated. A large number of proteoglycans have been implicated in the regulation of neurite outgrowth, providing signals that either promote or inhibit neurite outgrowth. Traditionally, the expression of heparan sulfate proteoglycans has been associated with neuritogenesis, while chondroitin sulfate proteoglycans appeared to provide inhibitory cues to growing neurites. However, it is not possible to establish a clear classification (28) . In fact, there are clear examples of chondroitin sulfate proteoglycans which provide promoting cues to the growth cones, while some heparan sulfate proteoglycans can interfere with growth cone movements and even induce growth cone collapse and retraction (28, see also references within). Heparan sulfate proteoglycans anchored to the cell surface may function as receptors for ECM components and bind growth factors such as FGF or NGF (15). Ard and Bunge (29) have observed colocalization of heparan sulfate proteoglycans and laminin on the astrocyte surface in vitro and have noted that growing neurites contacted areas where these complexes were deposited. However, exogenous heparan sulfate can inhibit neurite growth in neurons growing on an L1 substrate (30) . Furthermore, Garcia-Abreu et al. (19) have shown that heparan sulfate contributes to the nonpermissive role of the midline glia in the growth of midbrain neurites.
Chondroitin sulfate has been considered to be inhibitory for neurite growth on the basis of the effects of non-neural GAGs as substrate (16) and of a correlation between its marked accumulation in the tectal midline and a barrier function for retinal axons (31) . However, some axon systems grow on a chondroitin proteoglycan path in vivo (32) . Furthermore, the DSD-1 proteoglycan and phosphacan, both of which are chondroitin sulfate proteoglycans, promote neurite outgrowth from midbrain and hippocampal neurons and this effect is mediated by the GAG structure (33, 34) . Chung et al. (35) have recently reported that the axon routing at the optic chiasm changes after enzymatic removal of chondroitin sulfate in mouse embryos and that navigation of normally projecting ipsilateral axons is perturbed, suggesting that chondroitin sulfate is involved in patterning the early phase of axonal growth across the midline and at a later stage controlling the axon divergence at the chiasm.
With this in vitro model using astrocyte cultures of the lateral and medial sectors from embryonic mouse midbrain, we have previously demonstrated that glial cells derived from different sectors of the midbrain differ in their ability to support neuritic growth of midbrain neurons and in the pattern assumed by the ECM glycoprotein laminin (10, 11) . Neurons growing onto lateral astrocytic carpets, in which laminin displays a fibrillar configuration, extend long neurites, while neurons plated onto medial astrocytic carpets, where laminin assumes a punctate pattern, show only stunted or no processes. We also suggest that these differential glial properties might be, at least in part, ascribed to the differential ability to synthesize and/or to compartmentalize and/or to secrete GAGs (12) . Recently we observed that the GAG chain rather than the intact proteoglycan molecule might be responsible for the differential effects of the two glial types on neurite growth (19) .
Available information about our culture system suggests that chondroitin sulfate might not be responsible for the nonpermissive properties of medial glia since treatment of this glial type with chondroitin lyase had little functional effect (19) . In fact, the enzymatic treatment caused a significant reduction in the growth-supporting ability of lateral glia. Clearly, functional experiments with xyloside-treated cultures may help clarify the role of glycosaminoglycans in the growthmodulating properties of lateral and medial midbrain glia.
